Fibrosis: all 1,270 studies

Page 5 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.

• Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.CompletedNCT01283152Not applicableResults posted
• Study of Bavituximab and Sorafenib In Patients With Advanced Liver CancerCompletedNCT01264705Phase 1/2Results posted
• Intravenous Interferon During Liver TransplantCompletedNCT01192698Not applicableResults posted
• Use of Bevacizumab in Trabeculectomy SurgeryCompletedNCT01166594Phase 4Results posted
• Use of Methacetin Breath Test to Predict Liver Failure in Patients With CirrhosisCompletedNCT01157845Phase 3Results posted
• A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With TerlipressinCompletedNCT01143246Phase 3Results posted
• A Study to Investigate Pharmacodynamics and Pharmacokinetics of OPC-41061 in Patients With Hepatic EdemaCompletedNCT01114828Phase 3Results posted
• A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic EdemaCompletedNCT01050530Phase 3Results posted
• A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mgCompletedNCT01048788Phase 3Results posted
• Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective AbdominoplastyCompletedNCT01037985Phase 2Results posted
• Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast SurgeryCompletedNCT01037413Phase 2Results posted
• A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic EncephalopathyCompletedNCT00999167Phase 2Results posted
• Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal BleedingCompletedNCT00966355Phase 4Results posted
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR MutationTerminatedNCT00953706Phase 2Results posted
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D MutationCompletedNCT00909727Phase 3Results posted
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D MutationCompletedNCT00909532Phase 3Results posted
• Clinical and Therapeutic Implications of Fibrosis in Hypertrophic CardiomyopathyCompletedNCT00879060Phase 4Results posted
• Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic FibrosisCompletedNCT00854087Phase 2Results posted
• Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of MagnevistCompletedNCT00744939Results posted
• BreathID 13C-Methacetin Breath Test for Detecting CirrhosisCompletedNCT00736840Phase 3Results posted
• Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00662038Phase 3Results posted
• Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic SclerosisCompletedNCT00613171Phase 2Results posted
• Trental & Vitamin E for Radiation-Induced FibrosisCompletedNCT00583700Phase 2Results posted
• A Dose-defining Study of OPC-41061 in Treatment of Hepatic EdemaCompletedNCT00479336Phase 2Results posted
• Safety Study of Ivacaftor in Subjects With Cystic FibrosisCompletedNCT00457821Phase 2Results posted
• Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or CirrhosisCompletedNCT00347009Phase 4Results posted
• Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00287729Phase 3Results posted
• Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00287716Phase 3Results posted
• Study of Long-term Peg Intron vs. Colchicine in Non-responders.CompletedNCT00179413Phase 4Results posted
• FibroScan in Patients With Hepatitis B and C Presenting for Liver BiopsyCompletedNCT00125762Not applicableResults posted
• A Culturally Sensitive Values-Guided Aid for End of Life Decision-MakingCompletedNCT00122135Not applicableResults posted
• Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in CirrhosisCompletedNCT00108355Phase 4Results posted
• Podocyte RetinoidsCompletedNCT00098020Phase 2Results posted
• Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of CirrhosisCompletedNCT00076336Phase 3Results posted
• Treating Nonalcoholic Steatohepatitis (NASH) With MetforminCompletedNCT00063232Phase 2Results posted
• Treating Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00062764Phase 2Results posted
• Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3CompletedNCT00056862Phase 4Results posted
• Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)CompletedNCT00048724Phase 3Results posted
• PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)CompletedNCT00039871Phase 3Results posted
• Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney DiseaseCompletedNCT00028093Phase 4Results posted
• Pegylated Interferon to Treat Chronic Hepatitis DCompletedNCT00023322Phase 2Results posted
• Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected PatientsCompletedNCT00018031Phase 2Results posted
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentCompletedNCT00006164Phase 3Results posted
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)CompletedNCT00001959Phase 2Results posted
• Clinical Outcomes in Patients Presenting With Acute Variceal BleedingCompletedNCT07870850
• Effect of LSD on Renal Function in Cirrhotic Patients With Portal HypertensionCompletedNCT07811713
• Effect of LSD on Lipid Profiles Within 1 Year Postoperatively in Cirrhosis Patients With Portal Hypertension BleedingCompletedNCT07811700
• Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient MeasurementCompletedNCT07703540
• Clinical Characteristics of RecompensationActive, not recruitingNCT07651683
• Prophylactic Antibiotics in the Endoscopic Secondary Prevention of Cirrhotic Patients With Varices: a Retrospective StudyCompletedNCT07616466
• Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial ElastanceActive, not recruitingNCT07568275Early Phase 1
• The Application of Biomarkers in the Care of Patients With Atrial FibrillationWithdrawnNCT07565337
• Intravenous Ciprofloxacin Versus Intravenous Ceftriaxone: Spontaneous Bacterial Peritonitis in Cirrhosis of LiverCompletedNCT07552870Not applicable
• A Pilot Study of Mirabegron and Montelukast in Cirrhotic PatientsCompletedNCT07533565Phase 4
• Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)CompletedNCT07506642
• Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep ProblemsCompletedNCT07480096Phase 2
• Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver CirrhosisActive, not recruitingNCT07437638
• LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and InsomniaCompletedNCT07417163Not applicable
• Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal CancerCompletedNCT07368309
• DEFINITION OF THE GENOMIC LANDSCAPE OF MASLDCompletedNCT07249112Not applicable
• EDUCATE-C: Education on Cirrhosis -- Assessing Text vs VideoCompletedNCT07216807Not applicable
• TEAS for Variceal Bleeding Endoscopy in CirrhosisCompletedNCT07106658Not applicable
• Evaluation of a Nutrition Education Guide for Patients With CirrhosisCompletedNCT07090447Not applicable
• Lung Point of Care Ultrasound to Guide Albumin Administration in CirrhosisCompletedNCT07072572Phase 3
• The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary FibrosisCompletedNCT07031362Not applicable
• A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic EncephalopathyTerminatedNCT06987968Phase 2
• Human Umbilical Cord-mesenchymal Stem Cells Via Different Transplantation Routes in ESLDActive, not recruitingNCT06984497Not applicable
• A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis BronchiectasisActive, not recruitingNCT06981091Phase 2
• Effect of Non-Selective Beta-Blockers on Outcomes in Cirrhosis Patients After Hospitalization: A Retrospective Cohort Using Target Trial DesignActive, not recruitingNCT06977685
• WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)Active, not recruitingNCT06967805Phase 2
• The Accuracy of Ultrasonic Viscoelastic Imaging in Evaluating the Severity of Chronic Kidney DiseasesCompletedNCT06961162
• Remote Electrical Stimulation for Pain and Depression Treatment in CirrhosisActive, not recruitingNCT06932783Not applicable
• RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung CancerCompletedNCT06908005
• Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control TrialCompletedNCT06892366Not applicable
• Endosonographic Shear Wave Elastography to Assess Liver and Splenic FibrosisCompletedNCT06867731
• Serum Zinc and Serum Magnesium in Chronic Liver Disease PatientsCompletedNCT06827769
• RTX001 Autologous Engineered Macrophages for Liver CirrhosisActive, not recruitingNCT06823713Phase 1/2
• Minimally Invasive Active Release of Septa Bands for Cellulite and Connective Tissue Release for Fibrosis Treatment in Body Contouring SurgeryCompletedNCT06791564Not applicable
• Non-inferiority of Compression Bandage Alone in Lower Extremity Lymphedema ManagementCompletedNCT06750679Not applicable
• Radiological Spectrum Of Fatty Liver Correlate With High Resolution Ultrasonography Of Fibrosis And CirrhosisActive, not recruitingNCT06749522
• Effectiveness of Percutaneous Electrolysis in Subacute and Early Chronic Medial Gastrocnemius Muscle InjuriesCompletedNCT06713200Not applicable
• NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic PatientsCompletedNCT06688149Not applicable
• Triple Recipient Strategy Using Split, Domino, and Auxiliary TechniquesCompletedNCT06683820
• Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLDActive, not recruitingNCT06662851
• A Study of Mosliciguat in PH-ILDActive, not recruitingNCT06635850Phase 2
• Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial HypercholesterolemiaActive, not recruitingNCT06634160
• PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.Active, not recruitingNCT06604923
• Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode ArrayActive, not recruitingNCT06598059Not applicable
• A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 FibrosisWithdrawnNCT06594523Phase 3
• Protocol for Muscle Attenuation Cut-offs in CirrhosisCompletedNCT06593015
• Mobile Chat Messaging for Alcohol Reduction in Patients With Chronic Liver DiseasesActive, not recruitingNCT06587568Not applicable
• EJV Occlusion Pressure Measurement to Assess Intravascular Volume in Cirrhotic Patients During IV Albumin SubstitutionCompletedNCT06544161Not applicable
• The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in ChinaCompletedNCT06420791
• Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19CompletedNCT06383819Phase 3
• MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular SurfaceCompletedNCT06353776Not applicable
• The Association Between Albumin Administration and Short-term Rebleeding Risk in Cirrhosis Patients With Acute Variceal Hemorrhage and Stable HemodynamicsActive, not recruitingNCT06348004
• DIAbetes and NAFLDActive, not recruitingNCT06315361
• Spectroscopic Profiling of Extracellular Vesicles By Resonant Gold Nanostructures in the InfraredStatus unknownNCT06266195
• Metobolomics in the Characterisation of HECompletedNCT06245473
• Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?CompletedNCT06243965

← Fibrosis overview